Arcus Biosciences Inc.

8.16
-0.33 (-3.89%)
At close: Mar 28, 2025, 3:59 PM
8.21
0.49%
After-hours: Mar 28, 2025, 08:00 PM EDT

Arcus Biosciences Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 258M 117M 112M 382.88M 77.52M 15M 8.35M 1.41M n/a
Cost of Revenue n/a 340M 14M 7.06M 159M 78.48M 49.65M 2.61M 1.31M
Gross Profit 258M -223M 98M 375.82M -81.48M -63.48M -41.29M -1.2M -1.31M
Operating Income -330M -340M -280M 54.25M -124.23M -88.71M -54.86M -53.44M -18.18M
Interest Income 52M 41M 16M 657K 1.38M 5.2M 4.92M 359K 212K
Pretax Income -283M -301M -266M 54.65M -122.86M -84.71M -49.59M -53.08M -17.97M
Net Income -283M -307M -267M 53M -116.68M -75.93M -49.59M -53.08M -17.97M
Selling & General & Admin 120M 117M 104M 72.29M 42.4M 25.23M 13.57M 7.64M 3.94M
Research & Development 448M 340M 288M 256.35M 159.35M 78.48M 49.65M 47.22M 14.25M
Other Expenses 20M n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses 588M 457M 392M 328.63M 201.75M 103.71M 63.21M 54.85M 18.18M
Interest Expense 4M 2M 2M 260K n/a n/a 4.92M n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 588M 457M 392M 328.63M 201.75M 103.71M 63.21M 54.85M 18.18M
Income Tax 1M 6M 1M 1.81M -6.18M -8.78M 5.26M n/a n/a
Shares Outstanding (Basic) 90.1M 74M 72M 69.35M 54.79M 43.83M 34.62M 42.55M 24.55M
Shares Outstanding (Diluted) 90.1M 74M 72M 73.97M 54.79M 43.83M 34.62M 42.55M 24.55M
EPS (Basic) -3.14 -4.15 -3.71 0.76 -2.13 -1.73 -1.43 -1.25 -0.73
EPS (Diluted) -3.14 -4.15 -3.71 0.71 -2.13 -1.73 -1.43 -1.25 -0.73
EBITDA -269M -283M -250M 61.96M -118.47M -81.13M -51.2M -50.83M -16.87M
Depreciation & Amortization 10M 8M 14M 7.06M 4.39M 3.58M 3.66M 2.61M 1.31M